If retatrutide follows the typical regulatory pathway, a first approval for obesity could arrive in 2026 or 2027
Serious Complications of Ozempic, Wegovy, Mounjaro and other GLP-1 Medications GLP-1 medications such as Ozempic, Wegovy, Mounjaro, and others, have been linked to serious gastrointestinal illnesses and serious complications which may result in hospitalization or permanent injury
Unlimited Doctor Access: MEDVi gives you ongoing access to your clinical team whenever questions or concerns come up
Our compounded version delivers the same therapeutic effect at $179/month physician-supervised and pharmacy-dispensed
For findings to be broadly applicable, the study population needs to reflect real-world patients in terms of age, gender, medical history, and dosing
GLP-1 medications start with low doses that gradually increase over weeks, meaning the full appetite-suppressing effect takes longer to develop